Articles & Research from Venn Life Sciences

Evaluating Dosing Regimens of a Hepatitis C NS3 Inhibitor using PK/PD Modeling

Validation of an in Vivo Phenotyping Cocktail for the Early Detection of Inductive or Inhibitory Potential of New Drugs

A preliminary population pharmacokinetic model for dose selection of treosulfan used in conditioning treatment prior to haematopoietic stem cell transplantation (HSCT) in children

Once-Daily Regimens of the HCV NS3/4A-Protease Inhibitor TMC435350 are predicted to provide Therapeutic Exposure in Plasma and Liver

Selective Serotonergic Properties of Low-Dose Pipamperone May Enhance Antidepressant Effect: Preclinical Evidence

Population PK Modeling of Dapivirine Released from Vaginal Rings

Dapivirine is a non-nucleoside reverse transcriptase inhibitor with potent antiviral activity against HIV-1. The International Partnership for Microbicides (IPM) has developed a vaginal ring containing dapivirine (25 mg) for use as a microbicide to protect women against HIV infection through sexual intercourse.

1 2 3 … 6 Next »